Tuksu Engineering & Construction,Ltd. (KOSDAQ:026150)
3,725.00
+70.00 (1.92%)
At close: Oct 16, 2026
KOSDAQ:026150 Revenue
Tuksu Engineering & Construction,Ltd. had revenue of 55.41B KRW in the quarter ending June 30, 2026, with 15.00% growth. This brings the company's revenue in the last twelve months to 163.58B, down -17.75% year-over-year. In the year 2025, Tuksu Engineering & Construction,Ltd. had annual revenue of 149.02B, down -29.88%. That makes Tuksu Engineering & Construction,Ltd. the 21,155th largest company in the world by revenue and 1,146th in South Korea.
Revenue (ttm)
163.58B
Revenue Growth
-17.75%
P/S Ratio
0.40
Revenue / Employee
817.91M
Employees
200
Market Cap
65.36B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.02B | -63.51B | -29.88% |
| Dec 31, 2024 | 212.53B | -20.33B | -8.73% |
| Dec 31, 2023 | 232.86B | 29.91B | 14.73% |
| Dec 31, 2022 | 202.96B | -29.05B | -12.52% |
| Dec 31, 2021 | 232.01B | 33.15B | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ilji Technology | 862.30B |
| Sinsin Pharmaceutical | 123.05B |
| eSang Networks Co.,Ltd | 110.38B |
| Wiable | 74.73B |
| SMCG Co., Ltd. | 58.86B |
| Innometry | 51.44B |
| Amicogen | 46.69B |
| Optipharm.CO.,LTD | 23.59B |